GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0200 $0.0500 Thursday, 18th Apr 2024 CALA stock ended at $0.0251. This is 37.38% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 0% from a day low at $0.0251 to a day high of $0.0251.
90 days $0.0200 $0.120
52 weeks $0.0100 $0.500

Historical Calithera Biosciences prices

Date Open High Low Close Volume
2020-08-12 $4.27 $4.27 $4.00 $4.11 671 443
2020-08-11 $4.61 $4.61 $4.15 $4.16 926 234
2020-08-10 $4.57 $4.79 $4.55 $4.71 580 268
2020-08-07 $4.92 $4.92 $4.41 $4.51 3 420 676
2020-08-06 $5.07 $5.11 $4.90 $5.01 478 304
2020-08-05 $5.04 $5.14 $4.98 $5.08 427 245
2020-08-04 $4.85 $5.02 $4.78 $5.00 382 088
2020-08-03 $4.69 $4.90 $4.66 $4.87 625 048
2020-07-31 $4.86 $4.87 $4.65 $4.70 531 764
2020-07-30 $4.73 $4.94 $4.71 $4.86 421 578
2020-07-29 $4.76 $4.83 $4.65 $4.78 356 690
2020-07-28 $5.00 $5.03 $4.71 $4.75 557 248
2020-07-27 $5.04 $5.06 $4.83 $4.94 529 665
2020-07-24 $5.12 $5.22 $4.96 $5.01 484 539
2020-07-23 $5.26 $5.36 $5.11 $5.16 406 300
2020-07-22 $5.38 $5.42 $5.24 $5.27 381 000
2020-07-21 $5.52 $5.52 $5.34 $5.40 525 400
2020-07-20 $5.36 $5.51 $5.36 $5.49 371 700
2020-07-17 $5.21 $5.40 $5.18 $5.34 479 600
2020-07-16 $5.23 $5.30 $5.06 $5.24 391 100
2020-07-15 $5.17 $5.43 $5.10 $5.27 771 100
2020-07-14 $5.07 $5.20 $4.94 $5.10 688 500
2020-07-13 $5.26 $5.36 $5.04 $5.04 704 300
2020-07-10 $5.21 $5.30 $5.10 $5.15 369 200
2020-07-09 $5.23 $5.38 $5.10 $5.23 479 900
Click to get the best stock tips daily for free!

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas... CALA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT